YD Bio (YDESW) Total Current Liabilities (2024 - 2026)

YD Bio (YDESW) has reported Total Current Liabilities for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 41.96% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 41.96% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 99.38% from the prior year.
• Total Current Liabilities was $1.1 million for Q2 2026 at YD Bio, down from $1.6 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $263.1 million in Q4 2024 and troughed at $752935.0 in Q2 2025.
• A 3-year average of $66.6 million and a median of $1.4 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities sank 99.38% in 2025 and soared 41.96% in 2026, its largest moves.
• Over 3 years, Total Current Liabilities stood at $263.1 million in 2024, then plunged by 99.38% to $1.6 million in 2025, then sank by 34.97% to $1.1 million in 2026.
• The last three Total Current Liabilities figures came in at $1.1 million (Q2 2026), $1.6 million (Q4 2025), and $752935.0 (Q2 2025), per Business Quant data.